Luc-Matthieu Fornecker
6PUBLICATIONS
44CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Apr 18, 2023
Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low-Tumor Burden Follicular Lymphoma: Results of a LYSA Study.Guillaume Cartron, Emmanuel Bachy, Hervé Tilly
|Feb 17, 2023
Efficacy of a short sandwich protocol, methotrexate, gemcitabine, L-asparaginase and dexamethasone chemotherapy combined with radiotherapy, in localised newly diagnosed NK/T-cell lymphoma: A French retrospective study.Sammara Chaubard, Amira Marouf, David Lavergne
|Jul 22, 2022
Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial.Luc-Matthieu Fornecker, Julien Lazarovici, Igor Aurer
|Jun 22, 2021
Gonadal Function Recovery in Patients With Advanced Hodgkin Lymphoma Treated With a PET-Adapted Regimen: Prospective Analysis of a Randomized Phase III Trial (AHL2011).Isabelle Demeestere, Judith Racape, Julie Dechene
|Apr 17, 2021
Intravenous high-dose methotrexate based systemic therapy in the treatment of isolated primary vitreoretinal lymphoma: An LOC network study.Marion Lam, Valérie Touitou, Sylvain Choquet
|Apr 09, 2021
Temporal multiomic modeling reveals a B-cell receptor proliferative program in chronic lymphocytic leukemia.Cedric Schleiss, Raphael Carapito, Luc-Matthieu Fornecker
Pageof 1
Frequent Collaborators
3 joint publications
David Sibon
3 joint publications
René-Olivier Casasnovas
2 joint publications
Roch Houot
2 joint publications
Franck Morschhauser
2 joint publications
Gandhi Laurent Damaj
2 joint publications
Lucie Oberic
1 joint publications
Raphael Carapito
1 joint publications
Hugo Gonzalez
1 joint publications
Laurent Mauvieux
1 joint publications
Sarah Cianferani
